Insilico Medicine successfully received $110 million in financing to accelerate the innovation process of AI drug research and development and robotics labs.
Silicon-based flow DeepSeek-R1 and V3 APIs have been upgraded, and the batch reasoning function has been added, with a direct price reduction of 75%, and the cost-effectiveness has been significantly improved.
Luma AI open source IMM technology greatly improves image generation speed ten times, and optimizes the generation quality, bringing a revolutionary breakthrough in AI image processing.